Amarin Corp Plc\Uk
13.16xPrice / book
Market cap
$6.04B
Tangible equity (USD)
—
Price / tangible book
—
Price / book
13.16x
Net income / ending equity
-8.4%
Net income / ending assets
-5.8%
Efficiency ratio
—
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: AMRN stock price at premium vs RJF $14.39 current versus $2.95 implied using P/B multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at RJF's multiple
Implied fair value · at AMRN's multiple
Snapshot Sep 9, 2026, 4:00 PM ET
Metric by metric
Filter, sort, and scan the equity metrics that matter most for banks: book value, tangible book, returns, and operating efficiency.
Multiple premium
Lower is better
Profitability lag
Asset efficiency lag
Lower is better
Statements
Reported bank earnings and balances, with each company’s reporting period shown.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
Tangible book and profitability anchor a bank, not enterprise value.
Deposits and cash-like balances distort enterprise value for banks, so this section reads equity value, tangible book and profitability instead.
Price / book
Market cap
$6.04B
Tangible equity (USD)
—
Price / tangible book
—
Price / book
13.16x
Net income / ending equity
-8.4%
Net income / ending assets
-5.8%
Efficiency ratio
—
Price / tangible book
Market cap
$33.75B
Tangible equity (USD)
$10.66B
Price / tangible book
3.17x
Price / book
2.70x
Net income / ending equity
17.1%
Net income / ending assets
2.4%
Efficiency ratio
71.3%
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
AMARIN CORP PLC\UK · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
RAYMOND JAMES FINANCIAL, INC. · implied price per share
Bank model off — standard DCF modelling is disabled for financial institutions.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider banking comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
LIGAND PHARMACEUTICALS INC
AMRN vs LGND
Harmony Biosciences Holdings, Inc.
AMRN vs HRMY
SUPERNUS PHARMACEUTICALS, INC.
AMRN vs SUPN
Viatris Inc
AMRN vs VTRS
Organon & Co.
AMRN vs OGN
INCYTE CORP
AMRN vs INCY
Morgan Stanley
AMRN vs MS
The Goldman Sachs Group, Inc.
AMRN vs GS
SCHWAB CHARLES CORP
AMRN vs SCHW
Bank of America Corporation
AMRN vs BAC
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.